Back

Presence of Atrial Fibrillation (AF) is a poor prognostic marker in patients with Heart Failure with reduced Ejection Fraction (HFrEF) and Left Bundle Branch Block (LBBB)

30 August 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Interactions between atrial fibrillation and heart failure Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Shriya Deshpande

Deenanath Mangeshkar Hospital and Research Center, Pune (India)

6 More presentations in this session

Presentation thumbnail
Assessing stroke and mortality risk in heart failure: the CHA2DS2-VASc score's prognostic value in patients with and without atrial fibrillation - a systematic review and meta analysis
Doctor I. Kamel (Boston, US)
Abstract Slides Video
Presentation thumbnail
Proteomic biomarkers and biological mechanisms associated with atrial fibrillation in heart failure patients
Mr T. Petersen (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
The efficacy of catheter ablation compared to medical therapy in heart failure patients with concomitant atrial fibrillation: A meta-analysis of randomized controlled trials
Doctor M. Ishrak Khan (New York City, US)
Abstract Slides Video
Presentation thumbnail
Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction
Mr O. Otero Garcia (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
No improvement in atrial arrhythmia rates in patients on baroreflex activation therapy
Doctor V. Pham (Los Angeles, US)
Abstract Slides Video

Access the full session

Session thumbnail
Interactions between atrial fibrillation and heart failure

The Event

Event poster

ESC Congress 2024

30 August 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Influence of persistent atrial fibrillation on the prognosis of heart failure with preserved, mildly reduced, and reduced ejection fraction in women and men.
thumbnail
Congress Presentation
Atrial fibrillation in patients with heart failure with reduced ejection fraction: a real-world analysis on renal function and left ventricular ejection fraction changes with outcome implications
thumbnail
Congress Presentation
Is beta- blocker therapy beneficial among patients with heart failure and reduced ejection fraction with concomitant atrial fibrillation rhythm?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources